<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="brief-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id>
      <journal-id journal-id-type="iso-abbrev">Emerging Infect. Dis</journal-id>
      <journal-id journal-id-type="publisher-id">EID</journal-id>
      <journal-title-group>
        <journal-title>Emerging Infectious Diseases</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1080-6040</issn>
      <issn pub-type="epub">1080-6059</issn>
      <publisher>
        <publisher-name>Centers for Disease Control and Prevention</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">21801637</article-id>
      <article-id pub-id-type="pmc">3381568</article-id>
      <article-id pub-id-type="publisher-id">10-2028</article-id>
      <article-id pub-id-type="doi">10.3201/eid1708.102028</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Dispatch</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Neurologic Disorders and Hepatitis E, France, 2010</article-title>
        <alt-title alt-title-type="running-head">Running Title: Neurologic Disorders and Hepatitis E</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Despierres</surname>
            <given-names>Laura-Anne</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kaphan</surname>
            <given-names>Elsa</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Attarian</surname>
            <given-names>Shahram</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cohen-Bacrie</surname>
            <given-names>Stephan</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pelletier</surname>
            <given-names>Jean</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pouget</surname>
            <given-names>Jean</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Motte</surname>
            <given-names>Anne</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Charrel</surname>
            <given-names>R&#xE9;mi</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gerolami</surname>
            <given-names>Ren&#xE9;</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Colson</surname>
            <given-names>Philippe</given-names>
          </name>
        </contrib>
        <aff id="aff1">Author affiliations: Centre Hospitalo-Universitaire Timone, Marseille, France (L.-A. Despierres, E. Kaphan, S. Attarian, S. Cohen-Bacrie, J. Pelletier, J. Pouget , A. Motte, R. Charrel, P. Colson);</aff>
        <aff id="aff2">Universit&#xE9; de la M&#xE9;diterran&#xE9;e, Marseille (S. Cohen-Bacrie, R. Charrel, P. C<italic>o</italic>lson);</aff>
        <aff id="aff3">Centre Hospitalo-Universitaire Conception, Marseille (R. Gerolami)</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">Address for correspondence: Philippe Colson, P&#xF4;le des Maladies Infectieuses et Tropicales Clinique et Biologique, F&#xE9;d&#xE9;ration de Bact&#xE9;riologie-Hygi&#xE8;ne-Virologie, Centre Hospitalo-Universitaire Timone, 264 Rue Saint-Pierre 13385, Marseille CEDEX 05, France; email: <email xlink:href="philippe.colson@ap-hm.fr">philippe.colson@ap-hm.fr</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>8</month>
        <year>2011</year>
      </pub-date>
      <volume>17</volume>
      <issue>8</issue>
      <fpage>1510</fpage>
      <lpage>1512</lpage>
      <abstract>
        <p>We report meningitis with diffuse neuralgic pain or polyradiculoneuropathy associated with PCR-documented acute hepatitis E in 2 adults. These observations suggest that diagnostic testing for hepatitis E virus should be conducted for patients who have neurologic symptoms and liver cytolysis.</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <title>Keywords: </title>
        <kwd>Acute hepatitis E</kwd>
        <kwd>hepatitis E virus</kwd>
        <kwd>neurologic symptoms</kwd>
        <kwd>meningitis</kwd>
        <kwd>polyradiculoneuropathy</kwd>
        <kwd>France</kwd>
        <kwd>autochthonous hepatitis</kwd>
        <kwd>viruses</kwd>
        <kwd>dispatch</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>Hepatitis E virus (HEV), a major cause of acute hepatitis in tropical and subtropical countries, is emerging in industrialized countries, where an increasing number of autochthonous hepatitis E cases have been reported (<xref rid="R1" ref-type="bibr"><italic>1</italic></xref><italic>&#x2013;</italic><xref rid="R5" ref-type="bibr"><italic>5</italic></xref>). Nonetheless, the clinical spectrum of HEV infection still might be incompletely characterized. During the past decade, 12 cases of hepatitis E with neurologic signs and symptoms have been reported (<xref rid="R1" ref-type="bibr"><italic>1</italic></xref><italic>&#x2013;</italic><xref rid="R4" ref-type="bibr"><italic>4</italic></xref><italic>,</italic><xref rid="R6" ref-type="bibr"><italic>6</italic></xref><italic>&#x2013;</italic><xref rid="R13" ref-type="bibr"><italic>13</italic></xref>). We report 2 cases of meningitis or polyradiculoneuropathy in association with PCR-documented acute hepatitis E in France during 2010.</p>
    <sec>
      <title>The Cases</title>
      <p>Case 1 occurred in a 54-year-old woman hospitalized in August 2010 for subacute diffuse paresthesia and pain of the limbs (with ulnar localization on upper limbs and proximal pain in legs), headaches, cervicalgia, photophonophobia, transient fever, and nausea. Reflexes were all present, without pyramidal signs. No abnormalities were found by medullar magnetic resonance imaging. Nerve conduction study was not done because of rapid clinical improvement beginning &lt;1 week after onset. The patient had no notable medical history. At admission, alanine aminotransferase level was 566 IU/L (reference values 8&#x2013;34 IU/L), &#x3B3;-glutamyl transferase level was 184 IU/L (reference 9&#x2013;38 IU/L), alkaline phosphatase level was 125 IU/L (reference 42&#x2013;98 IU/L), and bilirubin was 11 &#xB5;mol/L (reference 5&#x2013;34 &#xB5;mol/L). Cerebrospinal fluid (CSF) was clear; protein and glucose levels were 1.03 g/L (reference 0.15&#x2013;0.45) and 3.4 mmol/L (reference 3.0&#x2013;4.5 mmol/L), respectively; leukocyte count was 74 cells/mm<sup>3</sup>, including 90% mononuclear cells; erythrocyte count was 1 cell/mm<sup>3</sup>. Immunoelectrophoresis performed in CSF and serum indicated rupture of the blood&#x2013;brain barrier. Antibiotherapy with ceftriaxone, amoxicillin, and acyclovir was introduced 2 days after admission and continued for 2 weeks. CSF culture remained sterile at day 5.</p>
      <p>Several infectious causes for neurologic symptoms and acute hepatitis were excluded by nucleic acid and serologic assays performed on serum and CSF (<xref ref-type="table" rid="TA.1">Table A1</xref>). In contrast, HEV infection was diagnosed by detection of anti-HEV immunoglobulin (Ig) M (cutoff optical density ratio &gt;10; threshold value 1 [Adaltis, Rome, Italy]) and by detection of HEV RNA in serum (<xref rid="R5" ref-type="bibr"><italic>5</italic></xref>). Concurrently, anti-HEV IgM (Assure, MP Diagnostics, Illkirch, France) and HEV RNA were detected in CSF. HEV RNA levels measured by real-time PCR were &#x2248;2 log greater in the serum (cycle threshold [C<sub>t</sub>] 27) than in CSF (C<sub>t</sub> 33). HEV RNA open reading frame 2 sequences were recovered from serum (GenBank accession nos. HQ702487 and HQ702490) and CSF (GenBank accession no. HQ702488) by using in-house protocols (<xref rid="R14" ref-type="bibr"><italic>14</italic></xref>); they showed 100% nt identity with each other. Phylogenetic analysis identified genotype 3, which is commonly found in autochthonous cases in France (<xref rid="R4" ref-type="bibr"><italic>4</italic></xref><italic>,</italic><xref rid="R5" ref-type="bibr"><italic>5</italic></xref>). No source for HEV transmission was identified, including eating undercooked pork or drinking unsafe water; the patient had returned from Greece 3 weeks before her hospitalization. She recovered fully within 2 weeks after onset of hepatitis and neurologic disorders. Liver parameters returned to within normal limits within 2 weeks, and HEV RNA was cleared in serum after 3 weeks.</p>
      <p>Case 2 occurred in a 49-year-old man hospitalized in July 2010 for acute proximal sensorimotor weakness of the limbs. Clinical examination showed proximal muscle weakness associated with paresthesia and pain of upper and lower limbs. Muscle stretch reflexes were diminished in the lower limbs. No pyramidal signs were evident. Nerve conduction study results were normal, and needle electromyography showed abnormal spontaneous activity and neurogenic recruitment in weak muscles. The diagnosis of acute inflammatory polyradiculoneuropathy was retained. Liver enzymes were elevated: alanine aminotransferase 78 IU/L (reference &lt;60 IU/L) and &#x3B3;-glutamyl transferase 81 IU/L (reference &lt;60 IU/L); bilirubin levels were within reference range. CSF was macroscopically clear; protein and glucose levels were 1.02 g/L (reference 0.15&#x2013;0.45 g/L) and 3.6 mmol/L (reference 2.2&#x2013;3.9 mmol/L), respectively. Leukocyte count was 10 cells/mm<sup>3</sup>, including 87% lymphocytes; erythrocyte count was 3 cells/mm<sup>3</sup>. CSF culture was sterile after 5 days. As in case 1, several infectious etiologies were excluded (<xref ref-type="table" rid="TA.1">Table A1</xref>). Anti-HEV IgM was detected in serum (optical density ratio &gt;10) but not in CSF. HEV RNA was detected by real-time PCR only in serum (C<sub>t</sub> 34). HEV RNA was of genotype 3 (GenBank accession no. HQ702489); nucleotide identity with sequences from case 1 was 91.5%. No source for HEV transmission was identified, and the patient had not traveled abroad. Clinical outcome spontaneously improved within 2 weeks. HEV RNA test results 2 months postadmission were negative.</p>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclusions</title>
      <p>In these 2 cases, the temporal association between acute hepatitis and neurologic signs and symptoms, atypical neurologic features, and exclusion of a large panel of other potential etiologies are incentive to consider HEV as a possible cause of meningitis, diffuse neuralgic pain, and polyradiculoneuropathy. The association of neurologic signs and symptoms with acute hepatitis E was previously reported for several patients (<xref ref-type="table" rid="TA.1">Table A1</xref>). Eight case-patients had Guillain-Barr&#xE9; syndrome (GBS) (<xref rid="R3" ref-type="bibr"><italic>3</italic></xref><italic>,</italic><xref rid="R4" ref-type="bibr"><italic>4</italic></xref><italic>,</italic><xref rid="R6" ref-type="bibr"><italic>6</italic></xref><italic>&#x2013;</italic><xref rid="R11" ref-type="bibr"><italic>11</italic></xref>), which has been associated with a variety of bacterial or viral infections, including hepatitis viruses other than HEV (<xref rid="R10" ref-type="bibr"><italic>10</italic></xref><italic>,</italic><xref rid="R11" ref-type="bibr"><italic>11</italic></xref><italic>,</italic><xref rid="R15" ref-type="bibr"><italic>15</italic></xref>). Four other reports described distinct clinical presentations of acute meningoencephalitis with seizure (<xref rid="R1" ref-type="bibr"><italic>1</italic></xref>), Bell palsy (<xref rid="R2" ref-type="bibr"><italic>2</italic></xref>), acute transverse myelitis (<xref rid="R12" ref-type="bibr"><italic>12</italic></xref>), and neuralgic amyotrophy (<xref rid="R13" ref-type="bibr"><italic>13</italic></xref>).</p>
      <p>In most cases, only a few potential etiologies for GBS were tested for. In addition, in all but 2 reported cases (<xref rid="R3" ref-type="bibr"><italic>3</italic></xref><italic>,</italic><xref rid="R4" ref-type="bibr"><italic>4</italic></xref>), HEV diagnosis was based only on detection of anti-HEV IgM in serum. Dalton et al. detected HEV genotype 3 RNA in serum from a patient with acute hepatitis E in association with GBS, whereas HEV RNA testing of CSF was negative (<xref rid="R3" ref-type="bibr"><italic>3</italic></xref>). Kamar et al. described polyradiculoneuropathy with central nervous system involvement in a kidney transplant recipient who had chronic hepatitis E 33 months after acute hepatitis E (<xref rid="R4" ref-type="bibr"><italic>4</italic></xref>). In this case, HEV RNA was sequenced concurrently in serum and CSF at hospitalization for neurologic involvement. By contrast, the 2 cases in our report occurred concomitantly with acute hepatitis E. In the patient reported by Kamar et al. and in case-patient 1 in this report, HEV RNA load was &#x2248;2 log lower in CSF than in serum (<xref rid="R4" ref-type="bibr"><italic>4</italic></xref>). Rupture of the blood&#x2013;brain barrier could have enabled passive entry of the virus into CSF. The negativity of HEV RNA testing in the CSF in case-patient 2 might be explained by lower titers in CSF than in serum because HEV RNA titer in serum was low. In the case reported by Kamar et al., phylogenetic analysis suggested that neurologic symptoms could be associated with emergence of neurotropic variants because clonal HEV RNA in CSF clustered apart from those found in serum. In case-patient 1 reported here, HEV sequences recovered from serum and CSF were 100% identical; nevertheless, they were compared on a short open reading frame 2 fragment (106 nt) and on samples collected at time of acute hepatitis E, whereas comparison was performed 33 months postacute hepatitis in the case reported by Kamar et al. Regarding the outcome of neurologic symptoms associated with acute hepatitis E, patients fully recovered within 1 and 24 weeks, except in the cases reported by Chalupa et al. (<xref rid="R10" ref-type="bibr"><italic>10</italic></xref>) and Kamar et al. (<xref rid="R4" ref-type="bibr"><italic>4</italic></xref>). In this latter case-patient, no improvement was noted after 4 months, and the patient died of decompensated cirrhosis.</p>
      <p>Previous and current observations suggest that HEV diagnostic testing should be performed for patients who have concurrent neurologic symptoms and liver cytolysis. Further investigations are needed to assess the actual prevalence of HEV infections in cases of neurologic disorders, especially those of unknown etiology.</p>
    </sec>
    <sec>
      <title>Addendum</title>
      <p>Kamar et al. recently reported neurologic complications in 7 (5.5%) patients among 126 with locally acquired acute and chronic HEV genotype 3 infection diagnosed during 2004&#x2013;2009 at 2 hospitals in the United Kingdom and France (Kamar N, Bendall RP, Peron JM, Cintas P, Prudhomme L, Mansuy JM, et al. Hepatitis E virus and neurologic disorders. Emerg Infect Dis. 2011;17:173&#x2013;9).</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="citation">
        <p><italic>Suggested citation for this article:</italic> Despierres L-A, Kaphan E, Attarian S, Cohen-Bacrie S, Pelletier J, Pouget J, et al. Neurologic disorders and hepatitis E, France, 2010. Emerg Infect Dis [serial on the Internet]. 2011 Aug [<italic>date cited</italic>]. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3201/eid1708.102028">http://dx.doi.org/10.3201/eid1708.102028</ext-link></p>
      </fn>
    </fn-group>
    <app-group>
      <app>
        <table-wrap id="TA.1" position="anchor">
          <label>Table A1</label>
          <caption>
            <title>Clinical features and laboratory findings for neurologic disorders associated with hepatitis E infection*</title>
          </caption>
          <table frame="hsides" rules="groups">
            <col width="69" span="1"/>
            <col width="1" span="1"/>
            <col width="39" span="1"/>
            <col width="4" span="1"/>
            <col width="26" span="1"/>
            <col width="112" span="1"/>
            <col width="35" span="1"/>
            <col width="49" span="1"/>
            <col width="40" span="1"/>
            <col width="138" span="1"/>
            <col width="40" span="1"/>
            <col width="40" span="1"/>
            <col width="44" span="1"/>
            <col width="11" span="1"/>
            <col width="40" span="1"/>
            <col width="40" span="1"/>
            <col width="44" span="1"/>
            <col width="82" span="1"/>
            <thead>
              <tr>
                <th rowspan="2" valign="top" align="left" scope="col" colspan="1">Reference and year</th>
                <th rowspan="2" colspan="2" valign="top" align="center" scope="colgroup">Country</th>
                <th rowspan="2" colspan="2" valign="top" align="center" scope="colgroup">Age, y/sex</th>
                <th rowspan="2" valign="top" align="center" scope="col" colspan="1">Neurologic symptoms</th>
                <th rowspan="2" valign="top" align="center" scope="col" colspan="1">ALT, IU/L</th>
                <th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1">CSF</th>
                <th rowspan="2" valign="top" align="center" scope="col" colspan="1">Other infectious etiologies excluded by serologic or molecular testing</th>
                <th colspan="3" valign="top" align="center" scope="colgroup" rowspan="1">Serum</th>
                <th rowspan="2" valign="top" align="left" scope="col" colspan="1"/>
                <th colspan="3" valign="top" align="center" scope="colgroup" rowspan="1">CSF</th>
                <th rowspan="2" valign="top" align="center" scope="col" colspan="1">Treatment/outcome</th>
              </tr>
              <tr>
                <th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1">Leukocytes, cells/mm<sup>3</sup></th>
                <th valign="top" align="center" scope="col" rowspan="1" colspan="1">Protein, g/L</th>
                <th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1">Anti-HEV IgM</th>
                <th valign="top" align="center" scope="col" rowspan="1" colspan="1">Anti-HEV IgG</th>
                <th valign="top" align="center" scope="col" rowspan="1" colspan="1">HEV RNA</th>
                <th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1">Anti-HEV IgM</th>
                <th valign="top" align="center" scope="col" rowspan="1" colspan="1">Anti-HEV IgG</th>
                <th valign="top" align="center" scope="col" rowspan="1" colspan="1">HEV RNA</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td colspan="3" valign="top" align="left" scope="col" rowspan="1">Cases from this study</td>
                <td colspan="2" valign="top" align="left" rowspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Case 1, 2010</td>
                <td colspan="2" valign="top" align="center" rowspan="1">France</td>
                <td colspan="2" valign="top" align="center" rowspan="1">54/F</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Meningitis with neuralgic pain: headaches, photophobia, diffuse paresthesia, and pain of upper and lower limbs</td>
                <td valign="top" align="center" rowspan="1" colspan="1">566</td>
                <td valign="top" align="center" rowspan="1" colspan="1">74</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.03</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Serum: HAV, HBV, HCV, HIV, measles virus, rubella virus, HSV, VZV, EBV, parvovirus B19, dengue virus, <italic>Leptospira</italic> spp., <italic>Brucella</italic> spp., <italic>Coxiella burnetii</italic>, <italic>Rickettsia conorii</italic>, <italic>R. typhi</italic>, <italic>R. felis</italic></td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+ Genotype 3</td>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+ Genotype 3</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Total recovery in 2 wk</td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1"/>
                <td colspan="2" valign="top" align="left" rowspan="1"/>
                <td colspan="2" valign="top" align="left" rowspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="center" rowspan="1" colspan="1">CSF: CMV, HSV, VZV, EBV, HHV6, Toscana virus, mumps virus, measles virus, <italic>Listeria monocytogene</italic>s, <italic>Mycobacteria</italic> spp., <italic>Mycoplasma</italic> spp., all bacteria (16S ribosomal RNA detection)</td>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Case 2, 2010</td>
                <td colspan="2" valign="top" align="center" rowspan="1">France</td>
                <td colspan="2" valign="top" align="center" rowspan="1">49/M</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Polyradiculoneuropathy: Proximal muscle weakness, paresthesia, and pain of upper and lower limbs</td>
                <td valign="top" align="center" rowspan="1" colspan="1">78</td>
                <td valign="top" align="center" rowspan="1" colspan="1">10</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.02</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Serum: HAV, HBV, HCV, HIV, EBV, CMV, VZV, parvovirus B19, mumps virus, brucellosis, <italic>Bartonella henselae, Bartonella quintana</italic></td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+ Genotype 3</td>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Clinical recovery in 2 wk</td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1"/>
                <td colspan="2" valign="top" align="left" rowspan="1"/>
                <td colspan="2" valign="top" align="left" rowspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="center" rowspan="1" colspan="1">CSF: EBV, HSV, VZV, enterovirus, Toscana virus, WNV, <italic>Borrelia burgdorferi</italic>, all bacteria (16S ribosomal RNA detection)</td>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td colspan="5" valign="top" align="left" scope="col" rowspan="1">Cases reported in the literature</td>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td colspan="5" valign="top" align="left" scope="col" rowspan="1"> Guillain-Barr&#xE9; syndrome:</td>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td colspan="2" valign="top" align="left" scope="row" rowspan="1"> (<xref rid="R6" ref-type="bibr"><italic>6</italic></xref>), 2000</td>
                <td colspan="2" valign="top" align="center" rowspan="1">India</td>
                <td valign="top" align="center" rowspan="1" colspan="1">50/M</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Generalized paresthesia, weakness of the lower limbs, hypotonia, areflexia</td>
                <td valign="top" align="center" rowspan="1" colspan="1">114</td>
                <td valign="top" align="center" rowspan="1" colspan="1">&lt;5</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.86</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Serum: HAV, HBV, HCV</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Improvement 2 wk after neurologic onset; total recovery within 1 mo</td>
              </tr>
              <tr>
                <td colspan="2" valign="top" align="left" scope="row" rowspan="1"> (<xref rid="R7" ref-type="bibr"><italic>7</italic></xref>), 2002</td>
                <td colspan="2" valign="top" align="center" rowspan="1">India</td>
                <td valign="top" align="center" rowspan="1" colspan="1">35/M</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Weakness of upper and lower limbs and of respiratory muscles</td>
                <td valign="top" align="center" rowspan="1" colspan="1">752</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Serum: HAV, HBV, HCV, HDV, HIV</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">IVIG; total recovery within 2 wk</td>
              </tr>
              <tr>
                <td colspan="2" valign="top" align="left" scope="row" rowspan="1"> (<xref rid="R8" ref-type="bibr"><italic>8</italic></xref>), 2005</td>
                <td colspan="2" valign="top" align="center" rowspan="1">India</td>
                <td valign="top" align="center" rowspan="1" colspan="1">58/F</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Muscular weakness, diffuse areflexia, left infranuclear facial palsy</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1,448</td>
                <td valign="top" align="center" rowspan="1" colspan="1">&lt;2</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.80</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Serum: HAV, HBV, HCV</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">IVIG, plasmapheresis; total neurologic recovery in 2 wk; tiver biochemistry normalized after about 5 wk</td>
              </tr>
              <tr>
                <td colspan="2" valign="top" align="left" scope="row" rowspan="1"> (<xref rid="R3" ref-type="bibr"><italic>3</italic></xref>), 2008</td>
                <td colspan="2" valign="top" align="center" rowspan="1">United Kingdom</td>
                <td valign="top" align="center" rowspan="1" colspan="1">42/M</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Paresthesia and weakness in lower limbs</td>
                <td valign="top" align="center" rowspan="1" colspan="1">632</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+ Genotype 3</td>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Total recovery after 3 mo</td>
              </tr>
              <tr>
                <td colspan="2" valign="top" align="left" scope="row" rowspan="1"> (<xref rid="R9" ref-type="bibr"><italic>9</italic></xref>), 2009</td>
                <td colspan="2" valign="top" align="center" rowspan="1">Belgium</td>
                <td valign="top" align="center" rowspan="1" colspan="1">66/M</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Progressive ataxia; weakness and paresthesia of legs, with ataxia and neuropathic pain</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1,813</td>
                <td valign="top" align="center" rowspan="1" colspan="1">&lt;5</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.72</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Serum: HAV, HBV, HCV, HIV, VZV, CMV, EBV, HSV, adenovirus, <italic>Campylobacter</italic> spp.</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">IVIG; progressive improvement of walking perimeter and pain within 4 mo</td>
              </tr>
              <tr>
                <td colspan="2" valign="top" align="left" scope="row" rowspan="1"> (<xref rid="R10" ref-type="bibr"><italic>10</italic></xref>), 2010</td>
                <td colspan="2" valign="top" align="center" rowspan="1">Czech Republic</td>
                <td valign="top" align="center" rowspan="1" colspan="1">65/M</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Loss of strength in upper limbs and partially in lower limbs; pain in both shoulders</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1,920</td>
                <td valign="top" align="center" rowspan="1" colspan="1">7</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Serum: HSV, EBV, CMV, HAV, HBV, HCV, enterovirus, inflluenza A/B virus, parainfluenza viruses 1&#x2013;3, adenovirus, tick-borne encephalitis virus, <italic>Borrelia burgdorferi</italic>, <italic>Anaplasma phagocytophilum,</italic>&#x2028;<italic>Chlamydia pneumoniae</italic>, <italic>Mycoplasma</italic> spp.</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+&#x2020;</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Persistence of residual tetraparesis 19 mo after onset (chronic demyelinating polyneuropathy); improvement after IVIG</td>
              </tr>
              <tr>
                <td colspan="2" valign="top" align="left" scope="row" rowspan="1"/>
                <td colspan="2" valign="top" align="left" rowspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="center" rowspan="1" colspan="1">CSF: VZV,HSV, enterovirus, <italic>A. phagocytophilum,</italic>&#x2028;<italic>C. pneumoniae</italic>, <italic>Mycoplasma</italic> spp. <italic>B. burgdorferi</italic>.</td>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td colspan="2" valign="top" align="left" scope="row" rowspan="1"> (<xref rid="R11" ref-type="bibr"><italic>11</italic></xref>), 2010</td>
                <td colspan="2" valign="top" align="center" rowspan="1">Ireland</td>
                <td valign="top" align="center" rowspan="1" colspan="1">40/M</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Progressive weakness of the legs; paresthesia of hands and feet, then quadriplegia, repiratory insufficiency, and facial weakness</td>
                <td valign="top" align="center" rowspan="1" colspan="1">57</td>
                <td valign="top" align="center" rowspan="1" colspan="1">&lt;5</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.38</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Serum: HAV, HBV, HCV, HIV, CMV, EBV</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+&#x2021;</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">IVIG, followed by plasmapheresis; total recovery within 6 mo</td>
              </tr>
              <tr>
                <td colspan="2" valign="top" align="left" scope="row" rowspan="1"> (<xref rid="R4" ref-type="bibr"><italic>4</italic></xref>), 2010</td>
                <td colspan="2" valign="top" align="center" rowspan="1">France</td>
                <td valign="top" align="center" rowspan="1" colspan="1">44/M</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Peripheral nerve involvement; proximal muscular weakness of the joints of the 4 limbs; bilateral pyramidal syndrome</td>
                <td valign="top" align="center" rowspan="1" colspan="1">105</td>
                <td valign="top" align="center" rowspan="1" colspan="1">7</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.76</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Serum: HBV, HCV, HIV, CMV, EBV</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+ Genotype 3</td>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
                <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+ Genotype 3</td>
                <td valign="top" align="center" rowspan="1" colspan="1">IVIG; no improvement; death 1 mo later from decompensated cirrhosis</td>
              </tr>
              <tr>
                <td colspan="2" valign="top" align="left" scope="row" rowspan="1"/>
                <td colspan="2" valign="top" align="left" rowspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="center" rowspan="1" colspan="1">CSF: CMV, HSV, VZV, JC virus, <italic>Cryptococcus</italic> antigen, <italic>Toxoplasma gondii, Candida</italic> spp</td>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td colspan="4" valign="top" align="left" scope="col" rowspan="1"> Other neurologic diagnosis</td>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td colspan="2" valign="top" align="left" scope="row" rowspan="1"> (<xref rid="R1" ref-type="bibr"><italic>1</italic></xref>), 2001</td>
                <td colspan="2" valign="top" align="center" rowspan="1">India</td>
                <td valign="top" align="center" rowspan="1" colspan="1">28/F</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Meningoencephalitis: nuchal rigidity; drowsiness; desorientation; bilateral Babinski reflex and seizure</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1,890</td>
                <td valign="top" align="center" rowspan="1" colspan="1">12</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.10</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Serum: HAV, HBV, HCV, HIV, EBV, <italic>Treponema pallidum</italic></td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+ at mo 6</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Improvement of neurologic symptoms in 3 wk</td>
              </tr>
              <tr>
                <td colspan="2" valign="top" align="left" scope="row" rowspan="1"> (<xref rid="R12" ref-type="bibr"><italic>12</italic></xref>), 2006</td>
                <td colspan="2" valign="top" align="center" rowspan="1">India</td>
                <td valign="top" align="center" rowspan="1" colspan="1">12/F</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Acute transverse myelitis: weakness of lower limbs with sphincter dysfunction, pyramidal syndrome</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Serum: HAV, HBV, HCV, measles virus, rubella virus, HSV</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Total recovery within 10 d without treatment</td>
              </tr>
              <tr>
                <td colspan="2" valign="top" align="left" scope="row" rowspan="1"> (<xref rid="R2" ref-type="bibr"><italic>2</italic></xref>), 2006</td>
                <td colspan="2" valign="top" align="center" rowspan="1">India</td>
                <td valign="top" align="center" rowspan="1" colspan="1">32/M</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Bell palsy: right-sided lower motor neuron facial palsy</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1,000</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NA</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Serum: HAV, HBV, HIV, <italic>T. pallidum</italic></td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Total recovery in 3 wk</td>
              </tr>
              <tr>
                <td colspan="2" valign="top" align="left" scope="row" rowspan="1"> (<xref rid="R13" ref-type="bibr"><italic>13</italic></xref>), 2009</td>
                <td colspan="2" valign="top" align="center" rowspan="1">United Kingdom</td>
                <td valign="top" align="center" rowspan="1" colspan="1">44/M</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Bilateral neuralgic amyotrophy of upper limbs</td>
                <td valign="top" align="center" rowspan="1" colspan="1">2,547</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Serum: HAV, HBV, HCV, <italic>Borrelia burgdorferi, Treponema pallidum</italic>, HTLV</td>
                <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="left" rowspan="1" colspan="1"/>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NT</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Resolution of pain 6 wk after onset; total recovery of sensory motor deficiency in 2 y</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p>*ALT, alanine aminotransferase level; CSF, cerebrospinal fluid; HEV, hepatitis E virus; Ig, immunoglobulin; HAV, hepatitis A virus; HBV, hepatitis B virus; HCV, hepatitis C virus; HSV, herpes simplex virus; VZV, varicella zoster virus; EBV, Epstein-Barr virus; +, positive; NT, not tested; CMV, cytomegalovirus; HHV6, human herpes virus 6; &#x2013;, negative; HDV, hepatitis D virus, WNV, West Nile virus; HDV, hepatitis D virus; IVIG, intravenous immunoglobulin; NA, not available; HTLV, human T-lymphotropic virus.&#x2028;&#x2020;Two weeks after first anti-HEV IgM detection.&#x2028;&#x2021;Weakly positive.</p>
          </table-wrap-foot>
        </table-wrap>
      </app>
    </app-group>
    <bio id="d35e1144">
      <p>Dr Despierres is a doctoral fellow in medical biology at the F&#xE9;d&#xE9;ration de Bact&#xE9;riologie-Hygi&#xE8;ne-Virologie of the P&#xF4;le des Maladies Infectieuses et Tropicales Clinique et Biologique, Centre Hospitalo-Universitaire Timone, Marseille, France. Her primary field of interest is microbiology.</p>
    </bio>
    <ref-list>
      <title>References</title>
      <ref id="R1">
        <label>1. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Kejariwal</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Roy</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Sarkar</surname>
<given-names>N</given-names></string-name>. <article-title>Seizure associated with acute hepatitis E.</article-title>
<source>Neurology</source>. <year>2001</year>;<volume>57</volume>:<fpage>1935</fpage><pub-id pub-id-type="pmid">11723302</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>2. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Dixit</surname>
<given-names>VK</given-names></string-name>, <string-name><surname>Abhilash</surname>
<given-names>VB</given-names></string-name>, <string-name><surname>Kate</surname>
<given-names>MP</given-names></string-name>, <string-name><surname>Jain</surname>
<given-names>AK</given-names></string-name>. <article-title>Hepatitis E infection with Bell's palsy.</article-title>
<source>J Assoc Physicians India</source>. <year>2006</year>;<volume>54</volume>:<fpage>418</fpage><pub-id pub-id-type="pmid">16909746</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Dalton</surname>
<given-names>HR</given-names></string-name>, <string-name><surname>Stableforth</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Thurairajah</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Hazeldine</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Remnarace</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Usama</surname>
<given-names>W</given-names></string-name>, <etal/>
<article-title>Autochthonous hepatitis E in southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease.</article-title>
<source>Eur J Gastroenterol Hepatol</source>. <year>2008</year>;<volume>20</volume>:<fpage>784</fpage>&#x2013;<lpage>90</lpage>
<pub-id pub-id-type="doi">10.1097/MEG.0b013e3282f5195a</pub-id><pub-id pub-id-type="pmid">18617784</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Kamar</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Izopet</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Cintas</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Garrouste</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Uro-Coste</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Cointault</surname>
<given-names>O</given-names></string-name>, <etal/>
<article-title>Hepatitis E virus induced neurological symptoms in a kidney-transplant patient with chronic hepatitis.</article-title>
<source>Am J Transplant</source>. <year>2010</year>;<volume>10</volume>:<fpage>1321</fpage>&#x2013;<lpage>4</lpage>
<pub-id pub-id-type="doi">10.1111/j.1600-6143.2010.03068.x</pub-id><pub-id pub-id-type="pmid">20346067</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Colson</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Borentain</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Queyriaux</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Kaba</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Moal</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Gallian</surname>
<given-names>P</given-names></string-name>, <etal/>
<article-title>Pig liver sausage as a source of hepatitis E virus transmission to humans.</article-title>
<source>J Infect Dis</source>. <year>2010</year>;<volume>202</volume>:<fpage>825</fpage>&#x2013;<lpage>34</lpage>
<pub-id pub-id-type="doi">10.1086/655898</pub-id><pub-id pub-id-type="pmid">20695796</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Sood</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Midha</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Sood</surname>
<given-names>N</given-names></string-name>. <article-title>Guillain-Barr&#xE9; syndrome with acute hepatitis E.</article-title>
<source>Am J Gastroenterol</source>. <year>2000</year>;<volume>95</volume>:<fpage>3667</fpage>&#x2013;<lpage>8</lpage><pub-id pub-id-type="pmid">11151929</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Kumar</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Bhoi</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Kumar</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Sharma</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Singh</surname>
<given-names>BM</given-names></string-name>, <string-name><surname>Gupta</surname>
<given-names>BB</given-names></string-name>. <article-title>Guillain-Barr&#xE9; syndrome and acute hepatitis E: a rare association.</article-title>
<source>J Indian Acad Clin Med.</source>
<year>2002</year>;<volume>3</volume>:<fpage>389</fpage>&#x2013;<lpage>91</lpage></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Kamani</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Baijal</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Amarapurkar</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Gupte</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Patel</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Kumar</surname>
<given-names>P</given-names></string-name>, <etal/>
<article-title>Guillain-Barr&#xE9; syndrome associated with acute hepatitis E.</article-title>
<source>Indian J Gastroenterol</source>. <year>2005</year>;<volume>24</volume>:<fpage>216</fpage><pub-id pub-id-type="pmid">16361768</pub-id></mixed-citation>
      </ref>
      <ref id="R9">
        <label>9. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Loly</surname>
<given-names>JP</given-names></string-name>, <string-name><surname>Rikir</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Seivert</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Legros</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Defrance</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Belaiche</surname>
<given-names>J</given-names></string-name>, <etal/>
<article-title>Guillain-Barr&#xE9; syndrome following hepatitis E.</article-title>
<source>World J Gastroenterol</source>. <year>2009</year>;<volume>15</volume>:<fpage>1645</fpage>&#x2013;<lpage>7</lpage>
<pub-id pub-id-type="doi">10.3748/wjg.15.1645</pub-id><pub-id pub-id-type="pmid">19340910</pub-id></mixed-citation>
      </ref>
      <ref id="R10">
        <label>10. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Chalupa</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Holub</surname>
<given-names>M</given-names></string-name>. <article-title>Jaundice complicated by an atypical form of Guillain-Barr&#xE9; syndrome.</article-title>
<source>J Clin Virol</source>. <year>2010</year>;<volume>49</volume>:<fpage>229</fpage>&#x2013;<lpage>30</lpage>
<pub-id pub-id-type="doi">10.1016/j.jcv.2010.07.017</pub-id><pub-id pub-id-type="pmid">20727820</pub-id></mixed-citation>
      </ref>
      <ref id="R11">
        <label>11. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Cronin</surname>
<given-names>S</given-names></string-name>, <string-name><surname>McNicholas</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Kavanagh</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Reid</surname>
<given-names>V</given-names></string-name>, <string-name><surname>O'Rourke</surname>
<given-names>K</given-names></string-name>. <article-title>Anti-glycolipid GM2-positive Guillain-Barr&#xE9; syndrome due to hepatitis E infection.</article-title>
<source>Ir J Med Sci</source>. <year>2011</year>;<volume>180</volume>:<fpage>255</fpage>&#x2013;<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1007/s11845-010-0635-7</pub-id><pub-id pub-id-type="pmid">21063804</pub-id></mixed-citation>
      </ref>
      <ref id="R12">
        <label>12. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Mandal</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Chopra</surname>
<given-names>N</given-names></string-name>. <article-title>Acute transverse myelitis following hepatitis E virus infection.</article-title>
<source>Indian Pediatr</source>. <year>2006</year>;<volume>43</volume>:<fpage>365</fpage>&#x2013;<lpage>6</lpage><pub-id pub-id-type="pmid">16651680</pub-id></mixed-citation>
      </ref>
      <ref id="R13">
        <label>13. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Fong</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Illahi</surname>
<given-names>M</given-names></string-name>. <article-title>Neuralgic amyotrophy associated with hepatitis E virus.</article-title>
<source>Clin Neurol Neurosurg</source>. <year>2009</year>;<volume>111</volume>:<fpage>193</fpage>&#x2013;<lpage>5</lpage>
<pub-id pub-id-type="doi">10.1016/j.clineuro.2008.09.005</pub-id><pub-id pub-id-type="pmid">18986757</pub-id></mixed-citation>
      </ref>
      <ref id="R14">
        <label>14. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Zhai</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Dai</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Meng</surname>
<given-names>J</given-names></string-name>. <article-title>Hepatitis E virus genotyping based on full-length genome and partial genomic regions.</article-title>
<source>Virus Res</source>. <year>2006</year>;<volume>120</volume>:<fpage>57</fpage>&#x2013;<lpage>69</lpage>
<pub-id pub-id-type="doi">10.1016/j.virusres.2006.01.013</pub-id><pub-id pub-id-type="pmid">16472882</pub-id></mixed-citation>
      </ref>
      <ref id="R15">
        <label>15. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Kang</surname>
<given-names>JH</given-names></string-name>, <string-name><surname>Sheu</surname>
<given-names>JJ</given-names></string-name>, <string-name><surname>Lin</surname>
<given-names>HC</given-names></string-name>. <article-title>Increased risk of Guillain-Barr&#xE9; syndrome following recent herpes zoster: a population-based study across Taiwan.</article-title>
<source>Clin Infect Dis</source>. <year>2010</year>;<volume>51</volume>:<fpage>525</fpage>&#x2013;<lpage>30</lpage>
<pub-id pub-id-type="doi">10.1086/655136</pub-id><pub-id pub-id-type="pmid">20642353</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
